OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characterizing Early T Cell Responses in Nonhuman Primate Model of Tuberculosis
Riti Sharan, Dhiraj Kumar Singh, Jyothi Rengarajan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 12
Riti Sharan, Dhiraj Kumar Singh, Jyothi Rengarajan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 12
Showing 12 citing articles:
Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy
Bindu Singh, Chivonne Moodley, Dhiraj Kumar Singh, et al.
JCI Insight (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Bindu Singh, Chivonne Moodley, Dhiraj Kumar Singh, et al.
JCI Insight (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Advancement in diagnostic approaches for latent tuberculosis: distinguishing recent from remote infections
Yarong Ding, Matthew Tze Jian Wong, Mohd Nor Norazmi, et al.
One Health Outlook (2025) Vol. 7, Iss. 1
Open Access
Yarong Ding, Matthew Tze Jian Wong, Mohd Nor Norazmi, et al.
One Health Outlook (2025) Vol. 7, Iss. 1
Open Access
Advances in host-directed therapy for tuberculosis and HIV coinfection: enhancing immune responses
Preena Prasanna, B. Garcia Herrera, Larry S. Schlesinger, et al.
Trends in Microbiology (2025)
Open Access
Preena Prasanna, B. Garcia Herrera, Larry S. Schlesinger, et al.
Trends in Microbiology (2025)
Open Access
Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis 1
Hongbo Shen, Enzhuo Yang, Ming Guo, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1790-1805
Open Access | Times Cited: 16
Hongbo Shen, Enzhuo Yang, Ming Guo, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1790-1805
Open Access | Times Cited: 16
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates
Elise Ishida, Devin T. Corrigan, Tingting Chen, et al.
EBioMedicine (2023) Vol. 99, pp. 104897-104897
Open Access | Times Cited: 7
Elise Ishida, Devin T. Corrigan, Tingting Chen, et al.
EBioMedicine (2023) Vol. 99, pp. 104897-104897
Open Access | Times Cited: 7
Response to Hypoxia and the Ensuing Dysregulation of Inflammation ImpactsMycobacterium tuberculosisPathogenicity
Allison N. Bucşan, Ashley V. Veatch, Dhiraj Kumar Singh, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 1, pp. 94-104
Open Access | Times Cited: 12
Allison N. Bucşan, Ashley V. Veatch, Dhiraj Kumar Singh, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 1, pp. 94-104
Open Access | Times Cited: 12
Spontaneous Control of SIV Replication Does Not Prevent T Cell Dysregulation and Bacterial Dissemination in Animals Co-Infected with M. tuberculosis
Ryan V. Moriarty, Mark A. Rodgers, Amy Ellis, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 12
Ryan V. Moriarty, Mark A. Rodgers, Amy Ellis, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 12
Immune Responses in Lung Granulomas during Mtb/HIV Co-Infection: Implications for Pathogenesis and Therapy
Deepak Kaushal, Dhiraj Kumar Singh, Smriti Mehra
Pathogens (2023) Vol. 12, Iss. 9, pp. 1120-1120
Open Access | Times Cited: 5
Deepak Kaushal, Dhiraj Kumar Singh, Smriti Mehra
Pathogens (2023) Vol. 12, Iss. 9, pp. 1120-1120
Open Access | Times Cited: 5
Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection
Bindu Singh, Riti Sharan, Gayathri Ravichandran, et al.
JCI Insight (2024) Vol. 9, Iss. 15
Open Access | Times Cited: 1
Bindu Singh, Riti Sharan, Gayathri Ravichandran, et al.
JCI Insight (2024) Vol. 9, Iss. 15
Open Access | Times Cited: 1
Immune responses to bacterial lung infections and their implications for vaccination
Visai Muruganandah, Andreas Kupz
International Immunology (2021) Vol. 34, Iss. 5, pp. 231-248
Open Access | Times Cited: 9
Visai Muruganandah, Andreas Kupz
International Immunology (2021) Vol. 34, Iss. 5, pp. 231-248
Open Access | Times Cited: 9
B and T lymphocyte attenuator as a C-reactive protein and IgA associated auxiliary diagnostic marker for pulmonary tuberculosis: a case-control study
Feifan Xu, Keyun Bian, Shouwei Wang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1370-1370
Open Access | Times Cited: 2
Feifan Xu, Keyun Bian, Shouwei Wang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1370-1370
Open Access | Times Cited: 2
Analysis of IFN-γ and CD4+ responses in comorbid and adult immunized cynomolgus monkey with inactivated SARS-CoV-2 vaccine candidate
Florentina Evelyn Purnomo, Sri Agus Sudjarwo, Suryo Kuncorojakti, et al.
Research Journal of Pharmacy and Technology (2023), pp. 4206-4212
Closed Access
Florentina Evelyn Purnomo, Sri Agus Sudjarwo, Suryo Kuncorojakti, et al.
Research Journal of Pharmacy and Technology (2023), pp. 4206-4212
Closed Access
B and T lymphocyte attenuator as a C-reactive protein and IgA associated auxiliary diagnostic marker for pulmonary tuberculosis: a case-control study
Feifan Xu, Keyun Bian, Shouwei Wang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1370-1370
Open Access
Feifan Xu, Keyun Bian, Shouwei Wang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1370-1370
Open Access
